Navigation Links
Explorer completes the map ... for the body's blueprint
Date:9/24/2007

An Australian researcher has completed some pioneering work which is the cellular equivalent of the human genome project.

Professor Patrick Tams 27-year exploration has mapped the movement of cells and tissues in developing mammalian embryos. It reveals how cells direct themselves to form specific parts of the body.

He was (today) awarded recognition at a national conference attended by leading biologists.

Professor Tam, of the Childrens Medical Research Institute, was awarded the Presidents' Medal of the Australia and New Zealand Society for Cell and Developmental Biology at the Combio 07 conference in Darling Harbour, Sydney.

He told the delegates how his teams studies on mice embryos, showing the movement of cells in the early stages of embryonic development, has been exciting at every new discovery point.

This work shows the precursors of different body parts and organs - where they are in the embryo and how they assemble into the final body plan. This 'fate map' will be used as a reference tool by scientists around the world to investigate developmental problems such as neurological defects or head, face and eye malformations, Professor Tam said.

Just how and when cells and tissue know where they are to go at critical stages one goes that way to become the spine, another this way to become the nose is recognised as a major step in cell and developmental biology.

In receiving his medal, Professor Tam joins earlier recipients including Professors Don Metcalf, John Kerr, Adrienne Clark, Peter Koopman and David Vaux.

Patrick Tam richly embodies the traditions of this award, said the Societys president, Associate Professor Alpha Yap. From the elegance and insight of his outstanding research, to his tireless efforts in peer review work and mentorship in our scientific community, he has been a model to us all.

Professor Tams research on how tissues follow a pattern in the early embryo provide fundamental insights into tissue organisation - for both good health and disease.


'/>"/>

Contact: Patrick Tam
029-267-2711
Research Australia
Source:Eurekalert

Related medicine news :

1. iGATE Completes Phase I Testing Of Meningitis Vaccine
2. Delhi Hospital Completes 100 Liver Transplants
3. Roche Completes Acquisition of BioVeris
4. Cynosure Introduces Higher Power Smartlipo(TM) LaserBodySculpting Workstation
5. Bush Unveils Latest Blueprint for Handling Bird Flu Pandemic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2017)... , ... September 21, 2017 , ... With ProSlideshow Portrait ... and easy to do. Users can select from up to two layers of subject ... click of a mouse all within Final Cut Pro X. , With ...
(Date:9/21/2017)... Church, VA (PRWEB) , ... September 21, 2017 ... ... FDAnews Webinar**, Sept. 26, 2017 — 1:30 p.m. – 3:00 p.m. ET, ... business. It’s easy to get things wrong, run afoul of The Quality System ...
(Date:9/21/2017)... ... September 21, 2017 , ... The American Addiction Treatment ... for professionals in the addiction treatment industry entitled: Special Investigations Unit (SIU) ... companies and state and federal governments are increasingly scrutinizing the addiction treatment industry ...
(Date:9/21/2017)... ... September 21, 2017 , ... ... of a new member survey conducted by the International Society of Hair ... from 2014 to 2016 rose 60 percent, with 635,189 procedures performed in 2016. ...
(Date:9/21/2017)... San Diego, Ca (PRWEB) , ... September 21, 2017 , ... ... and affordable services to its customers, and give back to the community. For over ... on of the most successful companies serving plumbing in San Diego. They ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... 2017  Eli Lilly and Company (NYSE: ... operations to more efficiently focus resources on developing ... Global workforce reductions, including those from a U.S. ... approximately 3,500 positions. With the ... of approximately $500 million that will begin to ...
(Date:9/7/2017)... BOTHELL, Wash. , Sept. 7, 2017   BioLife ... developer, manufacturer and marketer of proprietary clinical grade cell and ... media ("BioLife"), announces that Mike Rice , President and ... Rodman & Renshaw 19 th ... 3:25 p.m. Eastern time (12:25 p.m. Pacific time). The conference ...
(Date:9/6/2017)... 2017 Eli Lilly and Company (NYSE: ... data for galcanezumab and lasmiditan, two investigational treatments for ... Society (IHC) taking place Sept. 7-10 in ... new, long-term data from an open-label study evaluating the ... mg and 240 mg) for the prevention of migraine. ...
Breaking Medicine Technology: